TXN · Texas Instruments Inc - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · TXN

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$17.68B	$15.64B	$17.52B	$20.03B	$18.34B	$14.46B
Cost of Revenue	$7.60B	$6.55B	$5.97B	$6.26B	$5.19B	$5.19B
Gross Profit	$10.08B	$9.09B	$11.02B	$13.77B	$12.38B	$9.27B
R&D	$2.08B	$1.96B	$1.86B	$1.67B	$1.55B	$1.53B
SG&A	$1.86B	$1.79B	$1.82B	$1.70B	$1.67B	$1.62B
Total Operating Expenses	-	-	-	-	-	-
D&A	$1.92B	$1.51B	$1.18B	$925.00M	$755.00M	$733.00M
Operating Income	$6.02B	$5.46B	$7.33B	$10.14B	$8.96B	$5.89B
Interest Expense	-	-	-	-	-	-
Income Tax	$709.00M	$654.00M	$908.00M	$1.28B	$1.15B	$422.00M
Net Income	$5.00B	$4.80B	$6.51B	$8.75B	$7.77B	$5.59B
EPS - Basic	$5.47	$5.24	$7.13	$9.51	$8.38	$6.05
EPS - Diluted	$5.45	$5.20	$7.07	$9.41	$8.26	$5.97

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$3.23B	$3.20B	$2.96B	$3.05B	$4.63B	$3.11B
Accounts Receivable	$1.96B	$1.72B	$1.79B	$1.90B	$1.70B	$1.41B
Inventory	$4.80B	$4.53B	$4.00B	$2.76B	$1.91B	$1.96B
Accounts Payable	$756.00M	$820.00M	$802.00M	$851.00M	$653.00M	$415.00M
Current Assets	$13.75B	$15.03B	$15.12B	$14.02B	$13.69B	$10.24B
Total Assets	$34.59B	$35.51B	$32.35B	$27.21B	$24.68B	$19.35B
Current Liabilities	$3.16B	$3.64B	$3.32B	$2.98B	$2.57B	$2.39B
Long-term Debt	$13.55B	$12.85B	$10.62B	$8.23B	$7.24B	$6.25B
Total Liabilities	$18.31B	$18.61B	$15.45B	$12.63B	$11.34B	$10.16B
Stockholders' Equity	$16.27B	$16.90B	$16.90B	$14.58B	$13.33B	$9.19B
Retained Earnings	$52.24B	$52.26B	$52.28B	$50.35B	$45.92B	$42.05B

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$7.15B	$6.32B	$6.42B	$8.72B	$8.76B	$6.14B
Investing Cash Flow	($1.44B)	($3.20B)	($4.36B)	($3.58B)	($4.09B)	($922.00M)
Financing Cash Flow	($5.69B)	($2.88B)	($2.14B)	($6.72B)	($3.14B)	($4.55B)
CapEx	$4.55B	$4.82B	$5.07B	$2.80B	$2.46B	$649.00M
Free Cash Flow	$2.60B	$1.50B	$1.35B	$5.92B	$6.29B	$5.49B

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	57.0%	58.1%	62.9%	68.8%	67.5%	64.1%
Operating margin	34.1%	34.9%	41.8%	50.6%	48.8%	40.8%
EBITDA margin	44.9%	44.6%	48.6%	55.2%	53.0%	45.8%
Net margin	28.3%	30.7%	37.2%	43.7%	42.4%	38.7%
Free cash flow margin	14.7%	9.6%	7.7%	29.6%	34.3%	38.0%
FCF / Net income	0.52	0.31	0.21	0.68	0.81	0.98
R&D / Revenue	11.8%	12.5%	10.6%	8.3%	8.5%	10.6%
SG&A / Revenue	10.5%	11.5%	10.4%	8.5%	9.1%	11.2%
Effective tax rate	12.4%	12.0%	12.2%	12.8%	12.9%	7.0%
Return on assets	14.5%	13.5%	20.1%	32.2%	31.5%	28.9%
Return on equity	30.7%	28.4%	38.5%	60.0%	58.3%	60.9%
Return on invested capital	17.7%	16.2%	23.4%	38.8%	37.9%	35.5%
Liquidity
Current ratio	4.35	4.12	4.55	4.70	5.33	4.28
Quick ratio	2.83	2.88	3.35	3.77	4.58	3.47
Cash ratio	1.02	0.88	0.89	1.02	1.80	1.30
Leverage
Debt / Equity	0.83	0.76	0.63	0.56	0.54	0.68
Debt / Assets	0.39	0.36	0.33	0.30	0.29	0.32
Debt / EBITDA	1.71	1.84	1.25	0.74	0.75	0.94
Interest coverage	-	-	-	-	-	-
Equity multiplier	2.13	2.10	1.91	1.87	1.85	2.11
Liabilities / Assets	0.53	0.52	0.48	0.46	0.46	0.53
Efficiency
Asset turnover	0.51	0.44	0.54	0.74	0.74	0.75
Inventory turnover	1.58	1.45	1.49	2.27	2.72	2.66
Days sales outstanding	41d	40d	37d	35d	34d	36d
Days inventory outstanding	231d	252d	245d	161d	134d	137d
Days payable outstanding	36d	46d	49d	50d	46d	29d
Cash conversion cycle	235d	247d	233d	146d	122d	144d
Valuation
P / E	31.8x	36.1x	24.1x	17.6x	22.8x	27.5x
P / B	9.7x	10.2x	9.2x	10.5x	13.2x	16.7x
P / S	9.0x	11.0x	8.9x	7.6x	9.6x	10.6x
EV / EBITDA	21.2x	26.1x	19.3x	14.3x	18.4x	23.6x
Growth
Revenue growth (YoY)	13.0%	-10.7%	-12.5%	9.2%	26.9%	0.5%
Revenue CAGR (3y)	-4.1%	-5.2%	6.6%	11.7%	11.1%	-1.1%
Revenue CAGR (5y)	4.1%	1.7%	5.6%	6.0%	6.5%	2.2%
Gross profit growth (YoY)	10.9%	-17.5%	-20.0%	11.3%	33.5%	1.1%
Operating income growth (YoY)	10.2%	-25.5%	-27.7%	13.2%	52.0%	3.0%
Net income growth (YoY)	4.2%	-26.3%	-25.6%	12.6%	38.9%	11.5%
EPS growth (YoY)	4.8%	-26.4%	-24.9%	13.9%	38.4%	13.9%
EPS CAGR (3y)	-16.6%	-14.3%	5.8%	21.5%	13.9%	18.3%
EPS CAGR (5y)	-1.8%	-0.2%	4.8%	21.1%	18.9%	16.2%
FCF growth (YoY)	73.8%	11.0%	-77.2%	-5.9%	14.6%	-5.4%
FCF CAGR (5y)	-13.9%	-23.7%	-17.3%	4.9%	9.0%	8.1%
Book value growth (YoY)	-3.7%	0.0%	15.9%	9.3%	45.1%	3.1%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$17.68B total

Analog$14.01B · 79.2%

Embedded Processing$2.70B · 15.3%

All Other Segments$979.00M · 5.5%

Geographic

$17.68B total

US$6.76B · 38.2%

CN$3.78B · 21.4%

EMEA$3.75B · 21.2%

Rest Of Asia$1.89B · 10.7%

JP$1.17B · 6.6%

Rest Of World$331.00M · 1.9%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

2.92

Safe

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

7/9

Strong

✓Net income positive
✓Operating cash flow positive
✓ROA improved YoY
✓Cash flow > net income
✗Long-term debt decreased
✓Current ratio improved
✓No share dilution
✗Gross margin improved
✓Asset turnover improved

Peer comparison

Same SIC group: Semiconductors & Related Devices

Company	Revenue (last FY)	Net margin	ROE
AMKR	$6.71B	5.6%	8.4%
LSCC	$523.26M	0.6%	0.4%
CRDO	-	-	-
FSLR	$5.22B	29.3%	16.0%
NVDA	$215.94B	55.6%	76.3%

Comparing TEXAS INSTRUMENTS INC against the 5 most active filers in the same SIC group.

Dividends

$5.62/share trailing 12 months · +4.5% YoY

Ex-date	Per share
May 5, 2026	$1.4200
Jan 30, 2026	$1.4200
Oct 31, 2025	$1.4200
Jul 31, 2025	$1.3600
Apr 30, 2025	$1.3600
Jan 31, 2025	$1.3600
Oct 31, 2024	$1.3600
Jul 31, 2024	$1.3000
May 7, 2024	$1.3000
Jan 30, 2024	$1.3000
Oct 30, 2023	$1.3000
Jul 28, 2023	$1.2400
May 5, 2023	$1.2400
Jan 30, 2023	$1.2400
Oct 28, 2022	$1.2400
Jul 29, 2022	$1.1500
May 6, 2022	$1.1500
Jan 28, 2022	$1.1500
Oct 29, 2021	$1.1500
Jul 23, 2021	$1.0200
Apr 30, 2021	$1.0200
Jan 29, 2021	$1.0200
Oct 29, 2020	$1.0200
Jul 30, 2020	$0.9000